The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR)

被引:2
|
作者
Inchakalody, Varghese P. [1 ,2 ]
Hydrose, Shereena P. [1 ,2 ]
Krishnankutty, Roopesh [3 ]
Merhi, Maysaloun [1 ,2 ]
Therachiyil, Lubna [3 ,12 ]
Nair, Varun Sasidharan [7 ]
Elashi, Asma A. [8 ]
Khan, Abdul Q. [3 ]
Taleb, Sara [6 ]
Raza, Afsheen [1 ,2 ]
Yoosuf, Zeenath Safira K. M. [2 ,8 ]
Fernandes, Queenie [2 ,9 ]
Al-Zaidan, Lobna [1 ,2 ]
Mestiri, Sarra [1 ,2 ]
Taib, Nassiba [1 ,2 ]
Bedhiafi, Takwa [1 ,2 ]
Moustafa, Dina [1 ,2 ]
Assami, Laila [1 ,2 ]
Maalej, Karama Makni [1 ,2 ]
Elkord, Eyad [10 ,11 ]
Uddin, Shahab [4 ,5 ]
Al Homsi, Ussama [1 ,2 ]
Dermime, Said [1 ,2 ]
机构
[1] Hamad Med Corp, Natl Ctr Canc Care & Res, Doha, Qatar
[2] Hamad Med Corp, Interim Translat Res Inst, Translat Canc Res Facil, Doha, Qatar
[3] Hamad Med Corp, Translat Res Inst, Acad Hlth Syst, Doha, Qatar
[4] Acad Hlth Syst, Translat Res Inst, Doha, Qatar
[5] Acad Hlth Syst, Dermatol Inst, Doha, Qatar
[6] Hamad Bin Khalifa Univ, Genom & Precis Med, Doha, Qatar
[7] Helmholtz Ctr Infect Res, Dept Expt Immunol, Braunschweig, Germany
[8] Hamad Bin Khalifa Univ, Coll Hlth & Life Sci, Doha, Qatar
[9] Qatar Univ, Coll Med, Doha, Qatar
[10] Univ Nizwa, Nat & Med Sci Res Ctr, Translat Canc Res Facil, Nizwa, Oman
[11] Univ Salford, Sch Sci Engn & Environm, Biomed Res Ctr, Manchester, Lancs, England
[12] Qatar Univ, Coll Pharm, Doha, Qatar
关键词
Non small lung cancer; 5; Aza-CdR; Epigenetic regulation; NY-ESO-1; Apoptosis; Intrinsic and extrinsic apoptotic pathway; EXPRESSION; PROTEINS; 5-AZA-2'-DEOXYCYTIDINE; ENRICHMENT; GROWTH;
D O I
10.1016/j.ejphar.2023.175612
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dysregulated epigenetic modifications are common in lung cancer but have been reversed using demethylating agent like 5-Aza-CdR. 5-Aza-CdR induces/upregulates the NY-ESO-1 antigen in lung cancer. Therefore, we investigated the molecular mechanisms accompanied with the epigenetic regulation of NY-ESO-1 in 5-Aza-CdR-treated NCI-H1975 cell line. We showed significant induction of the NY-ESO-1 protein (**p < 0.0097) using Cellular ELISA. Bisulfite-sequencing demonstrated 45.6% demethylation efficiency at the NY-ESO-1 gene pro-moter region and RT-qPCR analysis confirmed the significant induction of NY-ESO-1 at mRNA level (128-fold increase, *p < 0.050). We then investigated the mechanism by which 5-Aza-CdR inhibits cell proliferation in the NCI-H1975 cell line. Upregulation of the death receptors TRAIL (2.04-fold *p < 0.011) and FAS (2.1-fold *p < 0.011) indicate activation of the extrinsic apoptotic pathway. The upregulation of Voltage-dependent anion-selective channel protein 1 (1.9-fold), Major vault protein (1.8-fold), Bax (1.16-fold), and Cytochrome C (1.39-fold) indicate the activation of the intrinsic pathway. We also observed the differential expression of protein Complement C3 (3.3-fold), Destrin (-5.1-fold), Vimentin (-1.7-fold), Peroxiredoxin 4 (-1.6-fold), Fascin (- 1.8-fold), Heme oxygenase-2 (-0.67-fold**p < 0.0055), Hsp27 (-0.57-fold**p < 0.004), and Hsp70 (-0.39-fold **p < 0.001), indicating reduced cell growth, cell migration, and metastasis. The upregulation of 40S ribosomal protein S9 (3-fold), 40S ribosomal protein S15 (4.2-fold), 40S ribosomal protein S18 (2.5-fold), and 60S ribo-somal protein L22 (4.4-fold) implied the induction of translation machinery. These results reiterate the decisive role of 5-Aza-CdR in lung cancer treatment since it induces the epigenetic regulation of NY-ESO-1 antigen, in-hibits cell proliferation, increases apoptosis, and decreases invasiveness.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Galbanic acid potentiates TRAIL induced apoptosis in resistant non-small cell lung cancer cells via inhibition of MDR1 and activation of caspases and DR5
    Kim, Yoon Hyeon
    Shin, Eun Ah
    Jung, Ji Hoon
    Park, Ji Eon
    Koo, Jinsuk
    Koo, Ja Il
    Shim, Bum Sang
    Kim, Sung-Hoon
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 847 : 91 - 96
  • [42] Master protocol to assess the safety and recommended Phase 2 dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma and non-small cell lung cancer.
    Schoenfeld, Adam J.
    Altan, Mehmet
    Owonikoko, Taofeek K.
    D'Angelo, Sandra
    Ladle, Brian H.
    Noujaim, Jonathan
    He, Kai
    Liebner, David
    Sacher, Adrian G.
    Haanen, John B. A. G.
    Yachnin, Jeffrey
    Huang, Chao
    Van Tine, Brian A.
    Hasan, Aisha
    Faitg, Thomas
    Butler, Emily
    Shalabi, Aiman
    Attia, Steven
    Araujo, Dejka M.
    CANCER RESEARCH, 2021, 81 (13)
  • [43] Master protocol to assess safety and recommended phase 2 dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma or non-small cell lung cancer (Substudies 1 and 2).
    Schoenfeld, Adam Jacob
    Altan, Mehmet
    Owonikoko, Taofeek K.
    D'Angelo, Sandra P.
    Ladle, Brian H.
    Noujaim, Jonathan Christopher
    He, Kai
    Liebner, David A.
    Sacher, Adrian G.
    Haanen, John B. A. G.
    Yachnin, Jeffrey
    Huang, Chao H.
    Van Tine, Brian Andrew
    Hasan, Aisha N.
    Faitg, Thomas H.
    Butler, Emily
    Shalabi, Aiman
    Attia, Steven
    Araujo, Dejka M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [44] Up-regulation of YPEL1 and YPEL5 and down-regulation of ITGA2 in erlotinib-treated EGFR-mutant non-small cell lung cancer: A bioinformatic analysis
    Wu, Xiaoli
    GENE, 2018, 643 : 74 - 82
  • [45] Circular RNA THBS1 promotes proliferation and apoptosis of non-small cell lung cancer cells by sponging miR-129-5p and regulating SOX4 expression
    Chen, Huan
    Wu, Guocheng
    Chen, Guozhen
    Wang, Wei
    Ruan, Fangfang
    JOURNAL OF BUON, 2020, 25 (04): : 1721 - 1727
  • [46] Safety, tolerability and activity of autologous T-cells with enhanced T-cell receptors specific to NY ESO 1/LAGE 1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer: A phase Ib/IIa randomised pilot study
    Reckamp, K. L.
    Akerley, W.
    Calvo, E.
    Clarke, J.
    Edelman, M. J.
    He, K.
    Moreno, V.
    Neal, J. W.
    Owonikoko, T. K.
    Patel, J. D.
    Patel, S. P.
    Riess, J. W.
    Sacher, A. G.
    Turcotte, S.
    Villaruz, L. C.
    Zauderer, M. G.
    Farsaci, B.
    Skoura, N.
    Chisamore, M.
    Johnson, M. L.
    ANNALS OF ONCOLOGY, 2019, 30 : 657 - +
  • [47] The long non-coding RNA PVT1/miR-145-5p/ITGB8 axis regulates cell proliferation, apoptosis, migration and invasion in non-small cell lung cancer cells
    Wei, C. M.
    Zhao, X. F.
    Qiu, H. B.
    Ming, Z.
    Liu, K.
    Yan, J.
    NEOPLASMA, 2020, 67 (04) : 802 - 812
  • [48] Up-Regulation of FSTL3, Regulated by lncRNA DSCAM-AS1/miR-122-5p Axis, Promotes Proliferation and Migration of Non-Small Cell Lung Cancer Cells
    Gao, Liang
    Chen, Xiaochen
    Wang, Yongxiang
    Zhang, Jianbin
    ONCOTARGETS AND THERAPY, 2020, 13 : 2725 - 2738
  • [49] ATM/miR-34a-5p axis regulates a p21-dependent senescence-apoptosis switch in non-small cell lung cancer: a Boolean model of G1/S checkpoint regulation
    Gupta, Shantanu
    Silveira, Daner A.
    Mombach, Jose Carlos M.
    FEBS LETTERS, 2020, 594 (02) : 227 - 239
  • [50] Silencing oncogene cell division cycle associated 5 induces apoptosis and G1 phase arrest of non-small cell lung cancer cells via p53-p21 signaling pathway
    Shen, Wei
    Tong, Dimin
    Chen, Jie
    Li, Hongxiang
    Hu, Zeyang
    Xu, Shuguang
    He, Sufang
    Ge, Zhen
    Zhang, Jianan
    Mao, Qiqi
    Chen, Hang
    Xu, Guodong
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (05)